cognitive cybersecurity intelligence
Eisai is expanding the scope of its cancer drug pipeline through a partnership with Bliss Biopharmaceutical, whose lead program addresses a hot oncology target that makes it a potential competitor to a blockbuster AstraZeneca product.
Under the collaboration agreement announced Monday,…
Source: medcitynews.com – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
STRIDE GPT – AI-powered Tool LLMs To Generate Threat Models CyberSecurityNews
Patients using Ozempic and other GLP-1 drugs are reporting a complication not listed among the drug’s most common side effects. We’re not talking about “Ozempic
A significant data exposure has revealed hundreds of thousands of private user conversations with Elon Musk’s AI chatbot, Grok, in public search engine results. The
Microsoft is investigating a significant service incident within Exchange Online, identified as EX1137017, which is preventing some users from sending or receiving emails through the
